Skip to main content
Premium Trial:

Request an Annual Quote

Advanced Biological Laboratories SARS-CoV-2 Genotyping Test Receives CE Mark

NEW YORK – Advanced Biological Laboratories announced on Tuesday that its DeepChek Assay Whole Genome SARS-CoV-2 Genotyping V1 has received CE-IVD registration.

The test, which leverages RT-PCR technology followed by next-generation sequencing, is intended to be used to amplify the whole genome of SARS-CoV-2 in upper respiratory samples from people who have already tested positive for the virus. It aims to identify the virus by variant to assist in clinical applications, the company said in a statement.

ABL's test covers more than 99 percent of the SARS-CoV-2 whole genome and can be used with a variety of PCR and NGS platforms, including Illumina's iSeq-100 and MiSeq instruments and Thermo Fisher Scientific's ProFlex PCR instrument. The test, which has an estimated turnaround time between 48 and 72 hours, is available in a 48-kit package and is adaptable to low- and high-throughput labs.

ABL noted that the assay is also compatible with downstream analysis software to identify SARS-CoV-2 genomic variations and variants such as the B.1.1.7 and B.1.351 variants, list genomic variations associated with clinical interpretations, and provide a summary report for clinicians.

In April, ABL received the CE-IVD mark for its RT-PCR UltraGene SARS-CoV-2 Triplex Assay and last year the company received CE-IVD marking for its UltraGene Combo2Screen SARS-CoV-2 qPCR assay.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.